JAMA Network Open 对新冠文章的考虑

最近转了一篇文章到JAMA Network Open，没想到又被拒了，它是这样说的：

We receive hundreds of papers examining different aspects of SARS-CoV-2 infections each month, and currently are publishing about 5% of those submitted. We do not publish case-reports, narrative reviews, or opinion pieces. We generally are not accepting any systematic reviews on this topic because the literature is evolving so rapidly. We also are generally not accepting models predicting outcomes of general patients with the infection, or complications that are well known at this point. Studies on therapies should be randomized trials in order to be considered.

希望对大家投稿有所帮助。